Narrow Results

This paper presents a brief overview of intellectual property rights and the various areas in proteomics to which IP rights may be applicable. Technology transfer, including licensing and business agreements, is not covered in this paper. Instead, issues and complications that are related to national and overseas patent prosecution in this relatively new field would be discussed.

Keeping Up Intellectual Property Lifelines for Life Sciences Ventures.

Impact of the SARS Outbreak on the Australian Economy.

Body, Heal Thyself?

The article is about the industry’s need for intellectual protection rights. It touches on the IP system: patents, trademarks, copyrights, trade secrets and exclusive drug approvals.

This paper investigates the distinctive technology protection strategies of entrepreneurial technology firms. In contrast with much popular opinion, it is reported that intellectual property features more prominently in the business of small entrepreneurial firms than it does in the business of large, established mature firms. The intellectual property portfolios of technology firms of all sizes and ages exhibit a rich array of instruments in addition to patents for protecting technology, including trade secrets, trademarks and copyright, together with licenses to externally sourced technology. The intellectual property profiles of technology firms appear to be influenced by their context, organizational profiles and corporate goals and by the character of their technology.